DESTAQUES
Vitória Strada
Carlo Acutis
Fluminense
Hugo Calderano

fiocruz

AO VIVO
Ouça a programação da Rádio Gaúcha
Prazo em xeque

Risco de atraso: Fiocruz e Butantan ainda não entregaram todos os documentos sobre vacinas à Anvisa

Estadão Conteúdo
image
image
Nova cepa

Variante amazonense do coronavírus surgiu no final de 2020 e é resultado de linhagem preexistente, aponta Fiocruz

Iarema Soares
(FILES) An undated handout picture released by the University of Oxford on November 23, 2020 shows a vial of the Universitys COVID-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech in partnership with pharmaceutical giant AstraZeneca. - Britain on December 30, 2020 became the first country in the world to approve the coronavirus vaccine developed by drug firm AstraZeneca and Oxford University, with a mass rollout planned from January 4, 2021. (Photo by John Cairns / University of Oxford / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT AFP PHOTO / UNIVERSITY OF OXFORD / John Cairns - NO MARKETING - NO ADVERTISING CAMPAIGNS - RESTRICTED TO ILLUSTRATING STORIES RELATED TO THE PARTICULAR VACCINE, EVENTS AND FACTS MENTIONED IN THE CAPTION - DISTRIBUTED AS A SERVICE TO CLIENTS / Editoria: HTHLocal: LondonIndexador: JOHN CAIRNSSecao: collective contractFonte: University of OxfordFotógrafo: Handout<!-- NICAID(14680347) -->
Corrida pela imunização

Anvisa aceita documentação da vacina de Oxford, mas pede mais dados da CoronaVac

Marcel Hartmann
PORTO ALEGRE, RS, BRASIL, 15/04/2020- Laboratório de Vírus Respiratórios e do Sarampo do Instituto Oswaldo Cruz (IOC/Fiocruz). Exames para Covid-19. Foto: Josué Damacena / IOC/Fiocruz/Divulgação<!-- NICAID(14477324) -->
Pandemia

Fiocruz deve pedir uso emergencial da vacina de Oxford até sexta-feira

Estadão Conteúdo
PORTO ALEGRE, RS, BRASIL, 15/04/2020- Laboratório de Vírus Respiratórios e do Sarampo do Instituto Oswaldo Cruz (IOC/Fiocruz). Exames para Covid-19. Foto: Josué Damacena / IOC/Fiocruz/Divulgação<!-- NICAID(14477324) -->
Pandemia

Por que a Fiocruz ainda não começou a produzir a vacina de Oxford no Brasil?

Marcel Hartmann
This picture taken on May 23, 2020 shows a laboratory technician holding a dose of a COVID-19 novel coronavirus vaccine candidate ready for trial on monkeys at the National Primate Research Center of Thailand at Chulalongkorn University in Saraburi. - After conclusive results on mice, Thai scientists from the centre have begun testing a COVID-19 novel coronavirus vaccine candidate on monkeys, the phase before human trials. (Photo by Mladen ANTONOV / AFP)<!-- NICAID(14508396) -->
Corrida por imunização

Em reunião com Fiocruz, Anvisa pede garantias de que vacina de Oxford importada da Índia é a mesma do Reino Unido

GZH
Capped vials are being pictured during filling and packaging tests for the large-scale production and supply of the University of Oxford’s COVID-19 vaccine candidate, AZD1222, on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics’ manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, during the COVID-19 infection, caused by the novel coronavirus. - Catalent Biologics’ manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222, providing large-scale vial filling and packaging to British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca. (Photo by Vincenzo PINTO / AFP)Editoria: HTHLocal: AnagniIndexador: VINCENZO PINTOSecao: pharmaceuticalFonte: AFPFotógrafo: STF<!-- NICAID(14626340) -->
Impasse

Fiocruz tenta reverter possível veto da Índia a exportação e garantir início da vacinação no Brasil em janeiro

Estadão Conteúdo
Fachada do edifício sede da Agência Nacional de Vigilância Sanitária (Anvisa).Fachada do edifício sede da Agência Nacional de Vigilância Sanitária (Anvisa).Local: BrasiliaIndexador: Marcelo Camargo/Agência BrasilFotógrafo: Reporter Fotografico<!-- NICAID(14641010) -->
Imunização

Gerente da Anvisa diz que autorização para vacina pode sair em menos de 10 dias após pedido de uso emergencial

GZH
(FILES) In this file photo taken on November 17, 2020 An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on November 17, 2020. - Britain on December 30, 2020 became the first country in the world to approve the coronavirus vaccine developed by drug firm AstraZeneca and Oxford University, with a mass rollout planned from January 4, 2021. (Photo by JUSTIN TALLIS / AFP)<!-- NICAID(14679789) -->
Pandemia

Anvisa aprova importação de dois milhões de doses da vacina de Oxford contra a covid-19

GZH
(FILES) In this file photo taken on November 17, 2020 An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca. - British drugs group AstraZeneca and the University of Oxford on November 23, 2020 said their jointly-developed vaccine against Covid-19 has shown an average efficacy of 70 percent in trials. The results ranged between 62 and 90 percent efficacy depending on the vaccine dosage. (Photo by JUSTIN TALLIS / AFP)Editoria: HTHLocal: LondonIndexador: JUSTIN TALLISSecao: epidemic and plagueFonte: AFPFotógrafo: STF<!-- NICAID(14650449) -->
Aposta contra covid-19

O que se sabe até agora sobre a vacina de Oxford

Marcelo Gonzatto, Marcel Hartmann
Exibir Mais

RBS BRAND STUDIO